Proxima Research: Kazakhstan and Uzbekistan showed growth in pharma markets early 2024
In the first quarter of 2024, the largest pharmaceutical markets in Central Asia grew: Kazakhstan’s retail market increased by 5%, and Uzbekistan’s by 8%. These insights come from Proxima Research, the Analytical Partner of the 5th Eurasian Pharmaceutical Summit which will be held by the Global Pharmaceutical Leaders’ Club on the 17th – 19th September in Tashkent and online.
Proxima Research’s report offers an in-depth look at the development trends of the pharmaceutical markets in Kazakhstan and Uzbekistan. It covers the various reforms implemented in these countries and highlights the aspects of promoting drugs in these markets.
For a comprehensive analysis of these dynamic markets, read the full Proxima Research report.
Proxima Research has been creating healthcare products and services for over 25 years, helping clients reach new heights of business efficiency. Their impressive portfolio includes partnerships with over 300 clients in 40 countries. The company provides expert solutions in market data, CRM / ETMS integration and support, HCP / HCO database management, omnichannel marketing, BI solutions, market research, and consulting, with a special focus on pharmaceutical business development.
The Eurasian Pharmaceutical Summit will delve into the development trends of the pharmaceutical markets in Central Asia, the Caucasus, and Eastern Europe. Analytical data provided by the summit partners, including Proxima Research, will equip attendees to identify new growth opportunities and refine their strategic direction.